Cost Effectiveness of Atorvastatin in Patients with Type 2 Diabetes Mellitus: A Pharmacoeconomic Analysis of the Collaborative Atorvastatin Diabetes Study in the Belgian Population

Author： Annemans L.   Marbaix S.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.30, Iss.2, 2010-02, pp. : 133-142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of the Effects of Policosanol and Atorvastatin on Lipid Profile and Platelet Aggregation in Patients with Dyslipidaemia and Type 2 Diabetes Mellitus

By Castaño G.  

Clinical Drug Investigation, Vol. 23, Iss. 10, 2003-01 ,pp. : 639-650

Adis International

Access to resources Recommend Favorite

Atorvastatin: A Review of its Use in the Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes Mellitus

By Croom Katherine F.   Plosker Greg L.  

Drugs, Vol. 65, Iss. 1, 2005-01 ,pp. : 137-152

Adis International

Access to resources Recommend Favorite

Beneficial Effect of Atorvastatin on Renal Function in Patients with Type 2 Diabetes

By Tanaka M  

The Journal of International Medical Research, Vol. 39, Iss. 4, 2011-07 ,pp. : 1504-1512

Field House Publishing

Access to resources Recommend Favorite

Effect of NCB-02, Atorvastatin and Placebo on Endothelial Function, Oxidative Stress and Inflammatory Markers in Patients with Type 2 Diabetes Mellitus: A Randomized, Parallel-Group, Placebo-Controlled, 8-Week Study

By Usharani P.  

Drugs in R&D, Vol. 9, Iss. 4, 2008-01 ,pp. : 243-250

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of ACE Inhibitor Treatment for Patients with Type 1 Diabetes Mellitus

By Frederick B. Dong  

PharmacoEconomics, Vol. 22, Iss. 15, 2004-01 ,pp. : 1015-1027

Adis International

Access to resources Recommend Favorite